Compliance
FDA’s Growing Expertise in Homeopathic Manufacturing
By George Bernstein, PhD If you have participated in AAHP Summits over the past couple of years, you are no doubt aware that FDA has raised the bar regarding…
Read MoreIntroducing a New Series on Supply Chain Management
By Mark Land, AAHP President This month, we’re kicking off a series of articles on supply chain management. Penned by Tim Clarot, who spent 20 years managing a virtual supply…
Read MoreIt’s Time to Renew FDA Drug Establishment Registrations!
By Leonard Krause, FDA Connect, Inc. If you haven’t renewed your FDA Drug Establishment Registration and certified your existing drug products, it’s not too late (or too early) to start.…
Read MoreDilution Process Validation Is Complex and Data Driven
By Mark Land, AAHP President There are more than 1,300 substances currently approved for inclusion within the Homeopathic Pharmacopoeia of the United States (HPUS). Based on discussions with homeopathic manufacturers,…
Read MoreNew FDA Report on the State of Pharmaceutical Quality Fiscal Year 2020
By Mark Land, AAHP President The US FDA’s Office of Pharmaceutical Quality published its 2020 report on the state of pharmaceutical quality on August 17, 2021. Homeopathic drug products…
Read MoreAn In-Depth Review of AAHP’s 2021 Summit
By Eric L. Foxman, Pharmacist, AAHP Secretary Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts…
Read MoreSuccess: Implementing HPUS Guidelines for FDA Compliance, Part 2
By Mark Land, AAHP President Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives.…
Read MoreHomeopathy’s Path Ahead: 5 Ways We’re Moving the Needle Together
A glance at AAHP and HPCUS’ multi-year, industry-wide initiative to clarify ambiguities in homeopathic manufacturing. Homeopathy’s path forward is a collective effort between manufacturers, scientists, homeopathic practitioners, and regulators.…
Read MoreThe Importance of AAHP’s 2021 Summit
Implementing HPUS Guidelines for FDA Compliance, Part 2 By Mark Land, AAHP President AAHP’s newsletter editor asked me to write an article explaining the importance of the upcoming…
Read MoreHomeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted…
Read More